BDBM50200913 CHEMBL3940280

SMILES: COc1ccc(CN2C[C@@H](C)N([C@@H](C)c3ccccc23)C(=O)NCc2ccccc2)cn1

InChI Key: InChIKey=BTJDQFBAKDDPOT-UXHICEINSA-N

Data: 3 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50200913   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Voltage-dependent T-type calcium channel subunit alpha-1H (Homo sapiens (Human))	BDBM50200913 (CHEMBL3940280) Show SMILES COc1ccc(CN2C[C@@H](C)N([C@@H](C)c3ccccc23)C(=O)NCc2ccccc2)cn1 |r| Show InChI InChI=1S/C26H30N4O2/c1-19-17-29(18-22-13-14-25(32-3)27-16-22)24-12-8-7-11-23(24)20(2)30(19)26(31)28-15-21-9-5-4-6-10-21/h4-14,16,19-20H,15,17-18H2,1-3H3,(H,28,31)/t19-,20+/m1/s1	UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	n/a	n/a	33	n/a	n/a	n/a	n/a	n/a	n/a
Actelion Pharmaceuticals Ltd. Curated by ChEMBL					Assay Description Channel blocking activity at recombinant human CaV 3.2 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins ...				J Med Chem 59: 10661-10675 (2016) Article DOI: 10.1021/acs.jmedchem.6b01356 BindingDB Entry DOI: 10.7270/Q2RV0QN8
					More data for this Ligand-Target Pair
Voltage-gated T-type calcium channel (Homo sapiens (Human))	BDBM50200913 (CHEMBL3940280) Show SMILES COc1ccc(CN2C[C@@H](C)N([C@@H](C)c3ccccc23)C(=O)NCc2ccccc2)cn1 |r| Show InChI InChI=1S/C26H30N4O2/c1-19-17-29(18-22-13-14-25(32-3)27-16-22)24-12-8-7-11-23(24)20(2)30(19)26(31)28-15-21-9-5-4-6-10-21/h4-14,16,19-20H,15,17-18H2,1-3H3,(H,28,31)/t19-,20+/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	n/a	n/a	45	n/a	n/a	n/a	n/a	n/a	n/a
Actelion Pharmaceuticals Ltd. Curated by ChEMBL					Assay Description Channel blocking activity at recombinant human CaV 3.1 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins ...				J Med Chem 59: 10661-10675 (2016) Article DOI: 10.1021/acs.jmedchem.6b01356 BindingDB Entry DOI: 10.7270/Q2RV0QN8
					More data for this Ligand-Target Pair
Voltage-gated T-type calcium channel (Homo sapiens (Human))	BDBM50200913 (CHEMBL3940280) Show SMILES COc1ccc(CN2C[C@@H](C)N([C@@H](C)c3ccccc23)C(=O)NCc2ccccc2)cn1 |r| Show InChI InChI=1S/C26H30N4O2/c1-19-17-29(18-22-13-14-25(32-3)27-16-22)24-12-8-7-11-23(24)20(2)30(19)26(31)28-15-21-9-5-4-6-10-21/h4-14,16,19-20H,15,17-18H2,1-3H3,(H,28,31)/t19-,20+/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	n/a	n/a	10	n/a	n/a	n/a	n/a	n/a	n/a
Actelion Pharmaceuticals Ltd. Curated by ChEMBL					Assay Description Channel blocking activity at recombinant human CaV 3.3 channel expressed in HEK293 cells assessed as inhibition of Ca2+ flux preincubated for 3 mins ...				J Med Chem 59: 10661-10675 (2016) Article DOI: 10.1021/acs.jmedchem.6b01356 BindingDB Entry DOI: 10.7270/Q2RV0QN8
					More data for this Ligand-Target Pair